HealthQuill Pharma
The International Organization for Migration has appealed for $18.5 million in global aid to provide healthcare services to migrants, internally displaced persons, and host communities in East and Southern Africa at the risk of mpox.
Drugs Health Pharma

UN body appeals for $18.5m aid to stop mpox spread among migrants in Africa

The International Organization for Migration has appealed for $18.5 million in global aid to provide healthcare services to migrants, internally displaced persons, and.

Read More
Molecules and microorganisms in the human body dramatically rise or fall at an average age of 44 and 60 affecting both the heart and immune functions, according to a Stanford Medicine study on the biology of ageing.
Drugs Health Pharma

Body undergoes tectonic molecular shifts at age 44, 60: Stanford Medicine

Molecules and microorganisms in the human body dramatically rise or fall at an average age of 44 and 60 affecting both the heart.

Read More
The US regulatory body has rejected Regeneron Pharmaceuticals, Inc.,’s blood cancer drug as it did not meet the pre-approval standards of the agency.
Drugs Health Pharma

US drug regulator blocks Regeneron’s blood cancer therapy 

The US regulatory body has rejected Regeneron Pharmaceuticals, Inc.,’s blood cancer drug as it did not meet the pre-approval standards of the agency.

Read More
Switzerland’s Basilea Pharmaceutica Ltd. will receive $1.25 million from its partner Pfizer Inc. after the latter exceeded the sales target for a licensed anti-fungal drug in the Asia-Pacific region and China.
Drugs Medical Pharma

Basilea Pharmaceutica to get $1.25m license fee from Pfizer

Switzerland’s Basilea Pharmaceutica Ltd. will receive $1.25 million from its partner Pfizer Inc. after the latter exceeded the sales target for a licensed.

Read More
Johnson & Johnson plans to acquire Israel’s privately-held V-Wave Ltd., for an upfront payment of $600 million, according to a statement from the US-based company.
Drugs Health Pharma

J&J plans to acquire Israel’s V-Wave by paying $600 million upfront

Johnson & Johnson plans to acquire Israel’s privately-held V-Wave Ltd., for an upfront payment of $600 million, according to a statement from the.

Read More
Walgreens Boots Alliance Inc., the second-largest pharmacy store chain in the US has bagged a $100 million gov­ern­ment fund­ing to ex­pand its clin­i­cal tri­al ca­pa­bil­i­ties, according to the company.
Drugs Health Pharma

Walgreens grabs $100 million from US government for decentralized trials

Walgreens Boots Alliance Inc., the second-largest pharmacy store chain in the US has bagged a $100 million gov­ern­ment fund­ing to ex­pand its clin­i­cal.

Read More
China’s drug regulator, the National Medical Products Association, has approved AstraZeneca Plc’s asthma drug.
Drugs Health Pharma

AstraZeneca’s asthma drug gets regulator’s approval in China

China’s drug regulator, the National Medical Products Association, has approved  AstraZeneca Plc’s asthma drug.

Read More
A new strain of monkeypox virus named as MPXV clade Ib, which originated in the Democratic Republic of the Congo recently, is behind the surge of cases reported and transmitted through sexual contact.
Drugs Health Pharma

New mpox virus strain, sexual contact, behind a surge in cases: WHO 

A new strain of monkeypox virus named as MPXV clade Ib, which originated in the Democratic Republic of the Congo recently, is behind.

Read More
Arbutus Biopharma Corporation and Genevant Sciences filed a lawsuit in a US court seeking compensation for Pfizer and BioNTech’s unlicensed use of its patents in making COVID-19 vaccines.
Health Medical Pharma

J&J’s $6.5B settlement plan amid ongoing talc lawsuits finds favour

HQ Team August 14, 2024: Johnson & Johnson (J&J) is nearing settlement of lawsuits alleging that its talc-based baby powder caused cancer. Over.

Read More
Pfizer Inc.’s vaccine trials on patients aged 18 and older with chronic respiratory diseases show a consistent safety profile and “strong neutralizing responses,” after a single jab, according to a company statement. 
Drugs Health Pharma

‘Strong neutralizing responses’ shown in RSV vaccine trials: Pfizer says

Pfizer Inc.’s vaccine trials on patients aged 18 and older with chronic respiratory diseases show a consistent safety profile and “strong neutralizing responses,”.

Read More